Ivantis

About:

Ivantis is focused on developing an innovative treatment for glaucoma which includes eye drops, laser therapy, and surgery.

Website: http://www.ivantisinc.com

Top Investors: RA Capital Management, Vertex Ventures, New Enterprise Associates, EDBI, Foresite Capital

Description:

Ivantis, Inc. is a company focused on developing an innovative treatment for Glaucoma. It is their goal to develop a less invasive, more effective option for the 60+ million people worldwide suffering from Primary Open Angle Glaucoma. As they successfully address this initial goal, it is then there intention to focus on innovative development for the treatment of other debilitating diseases within ophthalmology.

Total Funding Amount:

$132M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Irvine, California, United States

Founded Date:

2007-01-01

Contact Email:

info(AT)ivantisinc.com

Founders:

Number of Employees:

101-250

Last Funding Date:

2017-01-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai